TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Vision-related quality of life (VRQoL) improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative HEMA release amounts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: respiratory comfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete remission (CR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean shift in hallux valgus angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for recurrence of hallux valgus
Endpoint domain: Adverse events/effects
Primary endpoint: Platelet PS exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Caspase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean shell deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 86% remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Adjusted ACPR at day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted ACPR at day 42
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of Auto-CPAP in treating SDB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort with therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Orofacial dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental health and social service needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Titration success rate of ACE inhibitor doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum folate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight of the algal-DHA group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of the algal-DHA group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bayley mental and psychomotor development scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SANS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergence of complaints about decision-making ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Emergence of complaints about problem-solving ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presence of ovarian adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: death anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Neutropenia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Anemia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Thrombocytopenia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of bacteria on hands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Freedom from symptomatic PAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulp morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bridge thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Augmentation index (AIx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Reduction in redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mucus secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in chemosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in eyelid edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conjunctival cell surface expression of HLA-DR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Matrix metalloproteinase (MMP)-3 in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Interleukin (IL)-1β in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: psychosocial competence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient knowledge of stroke warning signs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient self-reported changes to improve lifestyle
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diet modification
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in fat free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal behavior after homicide
Endpoint domain: Adverse events/effects
Primary endpoint: Attempted suicide
Endpoint domain: Adverse events/effects
Primary endpoint: Diminished capacity of criminal responsibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean child-reported screen viewing at the weekend
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Servings of snacks per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Servings of high-energy drinks per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Servings of high-fat foods per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Larson score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete BME regression on MR images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median BME volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum tolerated dose of topotecan
Endpoint domain: Adverse events/effects
Primary endpoint: Contrast enhancement in tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: carers spent less time caregiving
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: decreased peer problems
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: increase in peak theta-alpha frequency (PTAF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in periodontal status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gain in attachment level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of spirochetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: intra-radicular push-out bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean midluteal phase progesterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Average number of days in the cycle with basal temperatures >37 degrees C during the luteal phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characteristics of NS waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characteristics of breathing during feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral state during feedings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in functional impairment of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in morning pre-dose trough FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of moderate/severe exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygen uptake at aerobic threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough resolution rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median verbal category descriptive score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Grade 3-4 hematological toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3-4 fatigue
Endpoint domain: Adverse events/effects
Primary endpoint: Absence of post‐PMC commissural mitral regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Immediate post‐PMC mitral valve area <1.8 cm2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resident overall satisfaction with the program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increased understanding of health‐related information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Greater commitment to medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aortic PWV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: augmentation index reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: central systolic BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cure rate of VVC after 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Cure rate of BV after 3 months
Endpoint domain: Mortality/survival
Primary endpoint: 10-week abstinence
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: 6-month abstinence
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Time to achieve complete CTI block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from AFL at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Local recurrence rates
Endpoint domain: Adverse events/effects
Primary endpoint: usual pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic/diastolic blood pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fatal cardiovascular event rate
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in Patient-Reported Outcomes (PROs)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Energy improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Effectiveness in blocking viral production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of viral turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of infected hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health status measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pertussis antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Gestational Diabetes Mellitus (GDM)
Endpoint domain: Mortality/survival
Primary endpoint: binge-drinking frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plaque index (PlI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in modified gingival index (MGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in renal NAE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in serum PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Urinary calcium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Plasma LDL-cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage of risk drinkers who decreased alcohol intake below 280 g weekly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone resorption marker levels decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone formation marker levels decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprocedural serum creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Peak serum cystatin C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean drop in HIV RNA (viral load)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with >1 log10 copies/mL drop in viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure relapse at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: BPRSd score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for pharmacological analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: time in active labor
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Impaired dual-task walking performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year relapse-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: risk of clinical failure events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of first hospitalization for worsening PAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apnoea-hypopnoea index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: relief from sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: morning diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death due to prostate cancer
Endpoint domain: Mortality/survival
Primary endpoint: Distant metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Local progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of intraoperative and postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Health check attendance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influenza vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infection-free time survival
Endpoint domain: Mortality/survival
Primary endpoint: number of CRB episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of hypersensitivity rash
Endpoint domain: Adverse events/effects
Primary endpoint: Mean daily PCA morphine equivalent consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VASPI scores during the first 8 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to decrease fat intake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to increase fruit and vegetable intake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in radiographic bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in 44-joint disease activity score (DAS44)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean symptom score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Region of sensory loss improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall improvement criteria met
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Catheter damage
Endpoint domain: Adverse events/effects
Primary endpoint: Benton Visual Retention Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Wechsler Memory Scale visual subscale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sexual dysfunction prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Odds of being sexually active
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SHC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportionate pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency contraception use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved generic and specific HRQL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: circulating PCSK9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coronary artery disease status and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: intima-media thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Infarction size assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: subjective pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain tolerance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Median time from randomisation to case conference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time from case conference to death/end of study
Endpoint domain: Mortality/survival
Primary endpoint: 1-month AWMSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Awareness of life support withdrawal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Support for organ donation after withdrawal of life support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Event-free survival at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Dental pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dental caries
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probability of successful vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Frequency of HIV-1 shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma HIV-1 RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Genital HSV-2 DNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: hunger
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Loss of gray-white matter differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increased T2-weighted signal in the ipsilateral AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Temporal lobe atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: FMA (Functional Movement Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RVGA reduction (Rehabilitation of Visual Gait Analysis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAC enhancement (Functional Ambulation Classification)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral desaturation load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life (HRQL) measured by HUI3
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health-related quality of life (HRQL) measured by SF-6D
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health-related quality of life (HRQL) measured by eQWB
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Readiness to get screened for colorectal cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of dilation sessions required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of response in days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adequate pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BLS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes